TRIM25 and hepatocellular carcinoma: Furthermore, we demonstrate that depleting TRIM21 or TRIM25 levels in HCC cells enhances sorafenib cytotoxicity, highlighting this vtRNA-protein complex as valuable target for a potential future anticancer strategy.